Selective omission of operative drains in pancreatic surgeries doesn’t worsen perioperative outcomes.

• In a study of 2,607 patients (1,855 pancreaticoduodenectomy, 752 distal pancreatectomy), outcomes with and without drains were comparable.
• Complications, 90-day mortality, and hospital stays were similar for those with a clinically relevant pancreatic fistula: no significant differences were found.
• Notably, patients without a fistula who had drains stayed in the hospital longer and experienced more thromboembolic events.

Surgeons can cautiously consider drain omission in their procedures without compromising patient safety.

Surgeons need to consider how perioperative quality of life fluctuates in pancreatic cancer patients to enhance outcomes.

• Quality of life scores significantly change between perioperative stages (p < 0.001).
• Main issues needing attention: pain and nausea in the first week, social functioning before discharge, and fatigue one month post-op.

Timely interventions on these factors can improve care and patient well-being.

• 66.79% of patients had ductal adenocarcinoma, indicating a majority skew in disease type affecting recovery profiles.

Surgical resection significantly enhances survival in borderline resectable and locally advanced pancreatic cancer compared to continued oncology therapy.

• Median overall survival (OS) is 39.0 months after resection versus 16.7 months with oncology therapy (p < 0.0001).
• In a matched cohort, OS is 42.6 months with resection compared to 18.6 months with oncology therapy (p < 0.0001).

Selecting patients with favorable chemotherapy responses for surgery can lead to better outcomes.

• Resection remains advantageous even with postoperative mortality included in the analysis.

This study shows that using a stapler for pancreatic transection in robot-assisted pancreaticoduodenectomy reduces clinically relevant postoperative pancreatic fistulas.

• The stapler method group had a cr-popf incidence of 13.1% compared to 31.5% in the conventional group (p=0.014).
• Body mass index is a risk factor for cr-popf (OR 1.34), while the stapler method reduced risk (OR 0.31).

Surgeons should consider the stapler method to improve postoperative outcomes without increasing complication rates.

• Postoperative amylase levels were higher with the stapler method, but acute pancreatitis rates were similar (1.6% vs. 1.4%).

Non-benchmark patients with perihilar cholangiocarcinoma can achieve good outcomes despite higher complexity.

• 64% of 648 patients analyzed were classified as non-benchmark, with median overall survival at 46 months.
• Postoperative liver failure occurred in 16.7%, bile leakage in 22.8%, and in-hospital mortality was 2.9%, all within benchmark limits.

Choose treatment strategies carefully: complexity impacts survival significantly, with 5-year rates dropping from 50.5% in medical only to 15.4% in dual patients.

• Left trisectionectomy had the highest mortality rate at 9.5%.